A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/13 (2006.01) A61K 31/445 (2006.01) A61P 25/00 (2006.01)
Patent
CA 2556969
The present invention relates to the treatment of behavioral disorders, especially agitation, associated with a central nervous system (CNS) disorder, especially Alzheimer's disease (AD), cerebrovascular disease (VaD), or Down's Syndrome, in a mammal, comprising administering to said mammal an 1- aminocyclohexane, alone or in combination with a acetylcholinesterase inhibitor. In one embodiment, the 1-aminocyclohexane is memantine.
Traitement de troubles du comportement, en particulier de l'agitation, associés au système nerveux central (SNC), en particulier de la maladie d'Alzheimer, des maladies cérébrovasculaires ou de la trisomie 21, chez un mammifère, qui consiste à administrer à ce mammifère un 1-aminocyclohexane, seul ou en combinaison avec un inhibiteur d'acétylcholinestérase. Dans un mode de réalisation, le 1-aminocyclohexane est de la mémantine.
Ferris Steven A.
Mcdonald Scott
Moebius Hans-Joerg
Reisberg Barry
Stoffler Albrecht
Merz Pharma Gmbh & Co. Kgaa
Perley-Robertson Hill & Mcdougall Llp
LandOfFree
Therapy using 1-aminocyclohexane derivatives for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapy using 1-aminocyclohexane derivatives for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapy using 1-aminocyclohexane derivatives for the... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1860462